Summary & Overview
HCPCS Level II J1810: Injection of Droperidol and Fentanyl Citrate, up to 2 mL
HCPCS Level II code J1810 denotes an injection of droperidol combined with fentanyl citrate, supplied in ampules up to 2 mL. This code captures administration of a combined sedative-analgesic product used in procedural sedation, anesthesia adjunct care, and acute pain management in settings such as hospitals, ambulatory surgical centers, and emergency departments. National recognition of a specific HCPCS Level II drug code matters because it standardizes billing for combined injectable products and supports consistent claims processing across payers.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context, typical sites of service, and the payer landscape. The publication provides benchmarks where available, notes on common billing modifiers and payer coverage considerations, and summarizes how J1810 is positioned relative to related injectable analgesic and sedative codes.
This analysis is intended for revenue cycle, coding, and clinical teams seeking a national-level reference for billing, coding alignment, and payer interactions related to the combined droperidol–fentanyl injectable product. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code J1810 describes an injection of droperidol and fentanyl citrate, up to a 2 mL ampule. This service represents a combined injectable medication used for procedural sedation, anesthesia adjunct, or management of severe procedural pain.
-
Service type: Injection of combined droperidol and fentanyl citrate
-
Typical site of service: Hospital inpatient or outpatient settings, ambulatory surgical centers, emergency departments, and other procedural locations where injectable sedatives/analgesics are administered
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an emergency department or ambulatory surgical center for procedural sedation and analgesia for a painful procedure such as closed reduction of a dislocated joint, fracture manipulation, or short painful gynecologic or endoscopic procedures. The attending emergency physician or anesthesiologist assesses the patient, obtains informed consent for sedation, establishes IV access, and administers medications. J1810 (injection, droperidol and fentanyl citrate, up to 2 ml ampule) is used when a combination of droperidol (an antiemetic and sedative) and fentanyl (an opioid analgesic) is administered for procedural sedation/analgesia. Typical workflow: pre-procedure evaluation and monitoring documentation (vital signs, airway assessment, ASA classification), medication administration record noting J1810 with dose and route, continuous monitoring during the procedure (cardiorespiratory monitoring, supplemental oxygen), procedural intervention (e.g., joint reduction), post-procedure recovery with monitoring until discharge criteria are met, and documentation of discharge instructions. Typical sites of service include the emergency department, ambulatory surgery center, and procedural clinics. Typical patient scenario example: a 45-year-old male with an anterior shoulder dislocation in the ED requiring closed reduction; after airway assessment and consent, the patient receives IV procedural sedation with droperidol/fentanyl per protocol, monitored by the ED team, undergoes successful reduction, and recovers in the PACU or ED observation area before discharge.
Coding Specifications
| Modifier | Description | When to Use |
|---|